Mannatech Inc (MTEX) stock
Close on Nov 11, 2026Market cap $16.54MP/E –Yield –
Mannatech Inc saw revenue fall 5.0% to $107.36M over the twelve months to Jun 30, 2026. Free cash flow was $1.60M. At the latest close the market valued the company at $16.54M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $16.54M
- P/E ratio
- –
- Price to sales
- 0.15
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 9.65%
Fundamentals
- Revenue
- $107.36M
- Net income
- -$7.41M
- EPS, diluted
- -$3.91
- Free cash flow
- $1.60M
- Book value per share
- -$2.58
- Diluted shares
- 2M
Trading
- Next earnings
- Nov 11, 2026 (estimated, after the close)
- Previous close
- $8.56
- Open
- $8.68
- Day's range
- $8.36 – $8.68
- Volume
- 15,174
- Average volume (20 days)
- 34,856
- Beta (5 years)
- 0.40
- 52-week range
- $3.80 – $9.97
- RSI (14 days)
- 54.9
- Volatility (1 year)
- 90.9%
- Relative volume
- 0.54×
- WACC
- 7.7%
Market cap history
Month-end market cap since 2009, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | MTEX | S&P 500 | Difference | MTEX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +9.0% | -2.4% | +11.4 pts | ||
| 3 months | +74.9% | -1.2% | +76.0 pts | ||
| Year to date | +3.9% | +12.3% | −8.4 pts | ||
| 1 year | -11.8% | +12.4% | −24.3 pts | ||
| 3 years | +0.9% | +78.8% | −77.9 pts | +0.3% | +21.4% |
| 5 years | -75.4% | +75.2% | −150.6 pts | -24.5% | +11.9% |
| 10 years | -26.4% | +311.1% | −337.5 pts | -3.0% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Mannatech filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- News
- Results
- Results
About Mannatech
Medicinal Chemicals & Botanical Products
Mannatech, Incorporated develops and sells nutritional supplements, skin care and anti-aging items, and weight-management products. The company operates in a single reporting segment within the nutritional supplement industry. Its product categories include integrative health, targeted health, weight and fitness, essentials, and Korean-inspired skin care formulations. Core offerings feature proprietary glyconutrient blends, vitamin complexes, and digestive aids. Third-party contractors manufacture all finished goods. The company sells to individual consumers, retail customers, and preferred customers who receive discounted pricing without participating in direct selling compensation.
Company profile, executives and historyMannatech stock: common questions
What is Mannatech's stock price?
MTEX closed at $8.57 on Nov 11, 2026, up 0.12% on the day. Over the past 52 weeks it traded between $3.80 and $9.97.
What is Mannatech's market cap?
Mannatech was worth $16.54M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is MTEX's P/E ratio?
Mannatech lost money over the twelve months to Jun 30, 2026 (diluted EPS -$3.91), so it has no meaningful P/E ratio.
How much revenue does Mannatech make?
Mannatech reported revenue of $107.36M for the twelve months to Jun 30, 2026, down 5.0% from a year earlier.
Does Mannatech pay a dividend?
No. Mannatech has not paid a cash dividend over the last twelve months.
When does Mannatech report earnings next?
Mannatech is expected to report Q3 FY2026 results on Nov 11, 2026, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has MTEX stock performed over the past year?
Including dividends, MTEX returned -11.8% over the past year, against +12.4% for the S&P 500.
Who are Mannatech's competitors?
Companies most similar to Mannatech by business, industry and size include FTLF, BTMD, NAII, NAGE, LFVN.
See a number that looks wrong?